Call for Experimental Medicine (EMI) collaborative research projects with Astrazeneca/MedImmune
The Office for Translational Research is pleased to open the call for Expressions of Interest (EoI) for PhD and ACL proposals for collaborative research projects for the EMI-AZ/MedI Scheme.
The Experimental Medicine Training Initiative (EMI), recently launched in May 2016, is a strategic scheme, supported by the University of Cambridge in partnership with the Cambridge University Hospitals, NIHR Cambridge Biomedical Research Centre and Industry Partners AstraZeneca/MedImmune and GSK. The aim of the scheme is to provide high-quality training in the design and execution of Experimental Medicine studies, with the purpose of equipping clinicians and non-clinician scientists with the knowledge and skills to lead Experimental Medicine studies in the future.
Please fill out the PhD or ACL EoI proforma and send to Dr. Mellone Marchong. To be eligible, all EoIs need to have an industry partner and secured funding for the clinical project. If either party does not yet have a collaboration they’re invited to get in touch at their earliest convenience (Email Dr. Mellone Marchong) so that mutual interest could be appropriately matched to academics or industry scientists.
Full Details about the EMI Scheme can be found on the Experimental Medicine Training Initiative website.
If you have any questions or to submit your proposal, contact Dr. Mellone Marchong at firstname.lastname@example.org by Oct 1 2017.
If you would like more information about the NIHR Cambridge BRC, please contact us.